vs

Side-by-side financial comparison of CPS TECHNOLOGIES CORP (CPSH) and RETRACTABLE TECHNOLOGIES INC (RVP). Click either name above to swap in a different company.

RETRACTABLE TECHNOLOGIES INC is the larger business by last-quarter revenue ($9.4M vs $8.2M, roughly 1.2× CPS TECHNOLOGIES CORP). CPS TECHNOLOGIES CORP runs the higher net margin — 0.2% vs -24.9%, a 25.0% gap on every dollar of revenue. On growth, CPS TECHNOLOGIES CORP posted the faster year-over-year revenue change (38.3% vs 4.0%). Over the past eight quarters, CPS TECHNOLOGIES CORP's revenue compounded faster (17.8% CAGR vs 11.5%).

Lesaka Technologies is a South-African financial technology company that is listed on the NASDAQ and Johannesburg Stock Exchange. Lesaka’s primary focus is on financial inclusion, offering financial services to previously underserved communities and merchants.

Retractable Technologies Inc is a specialized medical device manufacturer that designs, manufactures and distributes safety-engineered disposable medical products, including retractable syringes, safety needles and IV catheters. Its key customers are healthcare facilities, pharmaceutical companies and public health agencies across North America and global markets, helping reduce needlestick injury risks for medical personnel and patients.

CPSH vs RVP — Head-to-Head

Bigger by revenue
RVP
RVP
1.2× larger
RVP
$9.4M
$8.2M
CPSH
Growing faster (revenue YoY)
CPSH
CPSH
+34.3% gap
CPSH
38.3%
4.0%
RVP
Higher net margin
CPSH
CPSH
25.0% more per $
CPSH
0.2%
-24.9%
RVP
Faster 2-yr revenue CAGR
CPSH
CPSH
Annualised
CPSH
17.8%
11.5%
RVP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CPSH
CPSH
RVP
RVP
Revenue
$8.2M
$9.4M
Net Profit
$12.6K
$-2.3M
Gross Margin
14.9%
-16.2%
Operating Margin
-1.2%
-81.7%
Net Margin
0.2%
-24.9%
Revenue YoY
38.3%
4.0%
Net Profit YoY
101.3%
-162.3%
EPS (diluted)
$0.00
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPSH
CPSH
RVP
RVP
Q4 25
$8.2M
$9.4M
Q3 25
$8.8M
$10.1M
Q2 25
$8.1M
$10.4M
Q1 25
$7.5M
$8.3M
Q4 24
$5.9M
$9.1M
Q3 24
$4.2M
$10.3M
Q2 24
$5.0M
$6.0M
Q1 24
$5.9M
$7.6M
Net Profit
CPSH
CPSH
RVP
RVP
Q4 25
$12.6K
$-2.3M
Q3 25
$208.0K
$371.0K
Q2 25
$103.8K
$-87.5K
Q1 25
$96.0K
$-10.5M
Q4 24
$-995.2K
$3.8M
Q3 24
$-1.0M
$-1.9M
Q2 24
$-954.3K
$-14.2M
Q1 24
$-143.2K
$429.4K
Gross Margin
CPSH
CPSH
RVP
RVP
Q4 25
14.9%
-16.2%
Q3 25
17.1%
16.7%
Q2 25
16.5%
-1.0%
Q1 25
16.4%
-0.0%
Q4 24
-4.6%
-27.5%
Q3 24
-12.3%
-0.1%
Q2 24
-4.6%
-7.0%
Q1 24
15.3%
25.0%
Operating Margin
CPSH
CPSH
RVP
RVP
Q4 25
-1.2%
-81.7%
Q3 25
3.1%
-36.2%
Q2 25
1.7%
-49.1%
Q1 25
1.7%
-56.4%
Q4 24
-22.2%
-79.6%
Q3 24
-35.0%
-49.6%
Q2 24
-26.1%
-95.6%
Q1 24
-4.4%
-39.3%
Net Margin
CPSH
CPSH
RVP
RVP
Q4 25
0.2%
-24.9%
Q3 25
2.4%
3.7%
Q2 25
1.3%
-0.8%
Q1 25
1.3%
-126.6%
Q4 24
-16.8%
41.6%
Q3 24
-24.6%
-18.6%
Q2 24
-19.0%
-234.9%
Q1 24
-2.4%
5.7%
EPS (diluted)
CPSH
CPSH
RVP
RVP
Q4 25
$0.00
$-0.09
Q3 25
$0.01
$0.01
Q2 25
$0.01
$0.00
Q1 25
$0.01
$-0.35
Q4 24
$-0.07
$0.14
Q3 24
$-0.07
$-0.07
Q2 24
$-0.07
$-0.48
Q1 24
$-0.01
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPSH
CPSH
RVP
RVP
Cash + ST InvestmentsLiquidity on hand
$13.2M
$2.6M
Total DebtLower is stronger
$895.6K
Stockholders' EquityBook value
$24.6M
$74.4M
Total Assets
$29.5M
$142.6M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPSH
CPSH
RVP
RVP
Q4 25
$13.2M
$2.6M
Q3 25
$4.3M
$3.4M
Q2 25
$3.4M
$3.0M
Q1 25
$3.0M
$3.4M
Q4 24
$4.3M
$4.2M
Q3 24
$5.7M
$3.9M
Q2 24
$7.1M
$6.9M
Q1 24
$8.7M
$10.0M
Total Debt
CPSH
CPSH
RVP
RVP
Q4 25
$895.6K
Q3 25
Q2 25
Q1 25
Q4 24
$8.1K
$1.2M
Q3 24
$20.1K
Q2 24
$31.9K
Q1 24
$43.5K
Stockholders' Equity
CPSH
CPSH
RVP
RVP
Q4 25
$24.6M
$74.4M
Q3 25
$15.1M
$76.8M
Q2 25
$14.9M
$76.5M
Q1 25
$14.7M
$76.6M
Q4 24
$14.5M
$87.2M
Q3 24
$15.4M
$83.5M
Q2 24
$16.4M
$85.4M
Q1 24
$17.3M
$99.7M
Total Assets
CPSH
CPSH
RVP
RVP
Q4 25
$29.5M
$142.6M
Q3 25
$20.4M
$146.4M
Q2 25
$19.4M
$147.1M
Q1 25
$19.2M
$149.3M
Q4 24
$18.9M
$160.7M
Q3 24
$19.2M
$157.8M
Q2 24
$20.1M
$160.7M
Q1 24
$21.2M
$176.0M
Debt / Equity
CPSH
CPSH
RVP
RVP
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
0.01×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPSH
CPSH
RVP
RVP
Operating Cash FlowLast quarter
$243.6K
$-596.5K
Free Cash FlowOCF − Capex
$-487.0K
FCF MarginFCF / Revenue
-5.9%
Capex IntensityCapex / Revenue
8.9%
Cash ConversionOCF / Net Profit
19.34×
TTM Free Cash FlowTrailing 4 quarters
$-479.6K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPSH
CPSH
RVP
RVP
Q4 25
$243.6K
$-596.5K
Q3 25
$1.1M
$-1.3M
Q2 25
$649.3K
$-3.7M
Q1 25
$-1.3M
$-1.5M
Q4 24
$-3.5M
$-1.1M
Q3 24
$-1.2M
$-5.7M
Q2 24
$-1.0M
$-2.7M
Q1 24
$128.9K
$-2.0M
Free Cash Flow
CPSH
CPSH
RVP
RVP
Q4 25
$-487.0K
Q3 25
$876.8K
$-1.3M
Q2 25
$476.4K
$-4.1M
Q1 25
$-1.3M
$-1.6M
Q4 24
$-4.5M
$-1.4M
Q3 24
$-1.3M
$-6.5M
Q2 24
$-1.6M
$-2.8M
Q1 24
$-134.5K
$-2.2M
FCF Margin
CPSH
CPSH
RVP
RVP
Q4 25
-5.9%
Q3 25
10.0%
-13.4%
Q2 25
5.9%
-38.9%
Q1 25
-17.9%
-18.8%
Q4 24
-75.3%
-15.5%
Q3 24
-29.8%
-63.0%
Q2 24
-31.8%
-46.8%
Q1 24
-2.3%
-29.6%
Capex Intensity
CPSH
CPSH
RVP
RVP
Q4 25
8.9%
Q3 25
2.0%
0.9%
Q2 25
2.1%
3.2%
Q1 25
1.2%
1.0%
Q4 24
16.8%
3.3%
Q3 24
1.9%
7.7%
Q2 24
11.0%
2.0%
Q1 24
4.5%
3.0%
Cash Conversion
CPSH
CPSH
RVP
RVP
Q4 25
19.34×
Q3 25
5.05×
-3.39×
Q2 25
6.25×
Q1 25
-13.05×
Q4 24
-0.29×
Q3 24
Q2 24
Q1 24
-4.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons